Page last updated: 2024-08-22

ferric chloride and Arterial Occlusive Diseases

ferric chloride has been researched along with Arterial Occlusive Diseases in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (13.33)18.2507
2000's7 (46.67)29.6817
2010's6 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CH; Fu, WM; Gau, SS; Hsu, CC; Huang, SW; Huang, TF; Liao, HM; Liou, HC; Lu, DH; Tu, HJ1
Ahlstedt, S; Andersen, JF; Assumpção, TC; Francischetti, IMB; Kotsyfakis, M; Lukszo, J; Ma, D; Mather, TN; Mizurini, DM; Monteiro, RQ; Reyes, M; Ribeiro, JMC1
Jakubowski, JA; Mizuno, M; Ohno, K; Sugidachi, A; Tomizawa, A1
Chepurko, E; Covarrubias, R; Cowan, PJ; Dwyer, KM; Gumina, RJ; Huttinger, R; Huttinger, ZM; Novitskaya, T; Reynolds, A; Robson, SC; Stanfill, K; Wheeler, DG1
Dieudé, M; Gillis, MA; Lajoie, G; Levine, JS; Merhi, Y; Rauch, J; Théorêt, JF; Thorin, E1
Baumgartner, B; Eder, B; Jaki, T; Muchitsch, EM; Schiviz, A; Schwarz, HP; Wolfsegger, MJ1
Akkerman, JW; Cate, HT; Hauer, AD; Hildebrand, RB; Hoekstra, M; Korporaal, SJ; Kuiper, J; Meurs, I; Praticò, D; Van Berkel, TJ; Van Eck, M1
Dellas, C; Konstantinides, S; Loskutoff, DJ; Neels, JG; Schäfer, K1
Wang, X; Xu, L1
Astrof, S; Cambien, B; Chauhan, AK; Dole, VS; Hynes, RO; Matuskova, J; Piffath, CL; Wagner, DD1
Chen, CY; Cooley, BC; Schmeling, G1
Almus-Jacobs, F; Konstantinides, S; Loskutoff, DJ; Marchese, P; Ruggeri, ZM; Ware, J1
Boehncke, WH; Krahn, T; Ludwig, RJ; Nieswandt, B; Oostingh, GJ; Pozgajova, M; Schön, MP1
Fukazawa, T; Goto, Y; Hayashi, H; Inoue, Y; Komatsu, Y1
Kambayashi, J; Lockyer, S1

Other Studies

15 other study(ies) available for ferric chloride and Arterial Occlusive Diseases

ArticleYear
ARHGEF10 knockout inhibits platelet aggregation and protects mice from thrombus formation.
    Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:10

    Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Carotid Artery Diseases; Cell Shape; Chlorides; Disease Models, Animal; Ferric Compounds; Gene Knockout Techniques; Genotype; Hemostasis; Male; Mice, 129 Strain; Mice, Knockout; Myosin Light Chains; Phenotype; Phosphorylation; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Rho Guanine Nucleotide Exchange Factors; Selenoprotein P; Thrombosis; Time Factors

2017
Ixonnexin from Tick Saliva Promotes Fibrinolysis by Interacting with Plasminogen and Tissue-Type Plasminogen Activator, and Prevents Arterial Thrombosis.
    Scientific reports, 2018, 03-19, Volume: 8, Issue:1

    Topics: Animals; Arterial Occlusive Diseases; Chlorides; Ferric Compounds; Fibrinolysis; Mice; Noxae; Plasminogen; Saliva; Salivary Proteins and Peptides; Thrombosis; Ticks; Tissue Plasminogen Activator

2018
Prevention of occlusive arterial thrombus formation by a single loading dose of prasugrel suppresses neointimal hyperplasia in mice.
    Thrombosis research, 2015, Volume: 136, Issue:6

    Topics: Adenosine Diphosphate; Animals; Aorta; Arterial Occlusive Diseases; Arteries; Carotid Arteries; Chemokine CCL2; Chlorides; Ferric Compounds; Hyperplasia; Inflammation; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; Neointima; Platelet Aggregation; Prasugrel Hydrochloride; Pyridines; RNA, Messenger; Thrombosis; Time Factors; Transforming Growth Factor beta1

2015
Role of the CD39/CD73 Purinergic Pathway in Modulating Arterial Thrombosis in Mice.
    Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:9

    Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Arterial Occlusive Diseases; Blood Coagulation; Bone Marrow Transplantation; Chlorides; Disease Models, Animal; Endothelial Cells; Ferric Compounds; Genetic Predisposition to Disease; HEK293 Cells; Humans; Hydrolysis; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Monocytes; Phenotype; Platelet Activation; Thrombosis; Time Factors; Transfection

2016
Autoantibodies to heat shock protein 60 promote thrombus formation in a murine model of arterial thrombosis.
    Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:4

    Topics: Animals; Arterial Occlusive Diseases; Autoantibodies; Carotid Artery Diseases; Chaperonin 60; Chlorides; Disease Models, Animal; Ferric Compounds; Mice; P-Selectin; Regional Blood Flow; Reperfusion; Thrombosis; von Willebrand Factor

2009
Optimization, refinement and reduction of murine in vivo experiments to assess therapeutic approaches for haemophilia A.
    Laboratory animals, 2010, Volume: 44, Issue:3

    Topics: Animal Use Alternatives; Animal Welfare; Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Chlorides; Coagulants; Disease Models, Animal; Female; Ferric Compounds; Hemophilia A; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Regional Blood Flow; Research Design

2010
Deletion of the high-density lipoprotein receptor scavenger receptor BI in mice modulates thrombosis susceptibility and indirectly affects platelet function by elevation of plasma free cholesterol.
    Arteriosclerosis, thrombosis, and vascular biology, 2011, Volume: 31, Issue:1

    Topics: Animals; Arterial Occlusive Diseases; Blood Platelets; Bone Marrow Transplantation; Chlorides; Cholesterol, Dietary; Cholesterol, HDL; Disease Models, Animal; Ferric Compounds; Fibrinogen; Mice; Mice, Knockout; Platelet Activation; Platelet Adhesiveness; Platelet Aggregation; Scavenger Receptors, Class B; Thrombocytopenia; Thrombosis; Time Factors; Up-Regulation

2011
Inhibition of endogenous leptin protects mice from arterial and venous thrombosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2004, Volume: 24, Issue:11

    Topics: Animals; Antibodies, Blocking; Arterial Occlusive Diseases; Chlorides; Ferric Compounds; Leptin; Mice; Mice, Inbred C57BL; Receptors, Cell Surface; Receptors, Leptin; Venous Thrombosis

2004
An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research.
    Thrombosis research, 2005, Volume: 115, Issue:1-2

    Topics: Animals; Arterial Occlusive Diseases; Carotid Artery Diseases; Chlorides; Clopidogrel; Disease Models, Animal; Dose-Response Relationship, Drug; Ferric Compounds; Heparin; Kinetics; Mice; Regional Blood Flow; Research; Thrombosis; Ticlopidine

2005
Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles.
    Arteriosclerosis, thrombosis, and vascular biology, 2006, Volume: 26, Issue:6

    Topics: Alternative Splicing; Animals; Arterial Occlusive Diseases; Arterioles; Bleeding Time; Blood Coagulation; Blood Platelets; Chlorides; Ferric Compounds; Fibronectins; Haploidy; Heterozygote; Mice; Mice, Knockout; Platelet Adhesiveness; Protein Structure, Tertiary; Rats; Splanchnic Circulation; Thrombosis; Venules

2006
Increased venous versus arterial thrombosis in the Factor V Leiden mouse.
    Thrombosis research, 2007, Volume: 119, Issue:6

    Topics: Amino Acid Substitution; Animals; Arginine; Arterial Occlusive Diseases; Arteries; Chlorides; Disease Models, Animal; Factor V; Ferric Compounds; Gene Frequency; Glutamine; Homozygote; Mice; Mice, Inbred C57BL; Mutation; Thrombosis; Venous Thrombosis

2007
Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis.
    Journal of thrombosis and haemostasis : JTH, 2006, Volume: 4, Issue:9

    Topics: Animals; Arterial Occlusive Diseases; Carotid Artery Thrombosis; Chlorides; Disease Models, Animal; Ferric Compounds; Mice; Mice, Knockout; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins

2006
Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
    Haematologica, 2007, Volume: 92, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Arterial Occlusive Diseases; Chlorides; Drug Evaluation, Preclinical; Endothelial Cells; Ferric Compounds; Fibrinolytic Agents; Hemorheology; Humans; Immunoglobulin Fab Fragments; Macrolides; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Weight; Myocardial Infarction; Myocardial Reperfusion Injury; Neutrophils; Oligosaccharides; P-Selectin; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Lew; Sialyl Lewis X Antigen; Thrombosis

2007
Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Thrombosis and haemostasis, 1999, Volume: 81, Issue:2

    Topics: Amino Acid Sequence; Animals; Arginine; Arterial Occlusive Diseases; Arteriovenous Shunt, Surgical; Chlorides; Drug Evaluation, Preclinical; Ferric Compounds; Fibrinolytic Agents; Glass; Hemorrhage; Heparin; Hirudin Therapy; Hirudins; Molecular Sequence Data; Pipecolic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Serine Proteinase Inhibitors; Sulfonamides; Thrombin; Thrombosis; Vena Cava, Inferior; Venous Thrombosis

1999
Demonstration of flow and platelet dependency in a ferric chloride-induced model of thrombosis.
    Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:5

    Topics: Animals; Antifibrinolytic Agents; Antithrombins; Arterial Occlusive Diseases; Aspirin; Blood Platelets; Carotid Artery Diseases; Carotid Artery, Common; Chlorides; Ferric Compounds; Fibrinolytic Agents; Heparin; Hirudins; Immune Sera; Ligation; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Thrombosis; Tranexamic Acid

1999